Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Turk J Med Sci ; 51(4): 1917-1923, 2021 08 30.
Artículo en Inglés | MEDLINE | ID: mdl-33819976

RESUMEN

Background/aim: Postnatal corticosteroids are commonly used to treat bronchopulmonary dysplasia (BPD). We aimed to show whether S100 calcium-binding B (S100B), neuron-specific enolase (NSE), Tau protein or microtubule-associated protein tau (MAPT), and glial fibrillary acid protein (GFAP) levels would provide any evidence of early neurological damage in premature infants receiving postnatal low dose dexamethasone therapy for BPD treatment. Materials and methods: In this cohort study, 136 preterm infants diagnosed with BPD at ≤32 weeks of gestation formed the study group, and 64 preterm infants formed the control group. NSE, S100B, GFAP, and MAPT levels were first measured before the postnatal corticosteroid treatment in both the patient and the control group on the 28th day and, for a second time, after treatment termination in the patient group. Results: There were significant differences between the measured GFAP, MAPT, and NSE values of the BPD and control groups on the 28th day, whereas there was no significant difference between the measured S100B values of the two groups. There were a statistically significant difference between the NSE values measured on the 28th day and after the treatment within the BPD group, whereas no significant difference existed between the GFAP, MAPT, and S100B values. Conclusion: NSE levels, which indicate brain damage in the early period, increased in preterm babies with BPD who had been administered postnatal dexamethasone.


Asunto(s)
Corticoesteroides/efectos adversos , Lesiones Encefálicas , Displasia Broncopulmonar/tratamiento farmacológico , Recien Nacido Prematuro , Corticoesteroides/administración & dosificación , Lesiones Encefálicas/sangre , Lesiones Encefálicas/inducido químicamente , Estudios de Cohortes , Dexametasona , Proteína Ácida Fibrilar de la Glía , Humanos , Lactante , Recién Nacido , Proteínas Asociadas a Microtúbulos/sangre , Fosfopiruvato Hidratasa/sangre , Proteínas S100/sangre , Esteroides
2.
Turk J Pediatr ; 61(4): 618-621, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31990485

RESUMEN

Türe M, Bilici M, Akin A, Demir F, Balik H, Darakçi SM. Complete atrioventricular block associated with clozapine intoxication: case report. Turk J Pediatr 2019; 61: 618-621. Clozapine is one of the atypical anti-psychotic drugs used in the treatment of resistant schizophrenia. Although cardiac side-effects are rare, it has been reported that there may be development of myocarditis, dilated cardiomyopathy, postural orthostatic hypotension and prolonged QT duration. Complete atrioventricular (AV) block is characterized by the inability to transmit all of the atrial signal to the ventricles. Causes may be congenital, idiopathic or acquired which are associated with surgery, infection, or muscle disease. AV block is extremely serious and permanent pacemaker insertion is usually necessary for all patients. Complete AV block may develop due to clozapine intoxication through increase in vagal tonus, sinoatrial node (SN) and the inhibition of atrioventricular node signalling. The case presented here is of a 15-year old female patient who developed AV total cardiac block associated with the taking of clozapine in a suicide attempt.


Asunto(s)
Bloqueo Atrioventricular/inducido químicamente , Nodo Atrioventricular/fisiopatología , Clozapina/envenenamiento , Electrocardiografía/efectos de los fármacos , Adolescente , Antipsicóticos/envenenamiento , Bloqueo Atrioventricular/fisiopatología , Bloqueo Atrioventricular/terapia , Nodo Atrioventricular/efectos de los fármacos , Femenino , Humanos , Marcapaso Artificial , Intento de Suicidio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA